Microglial neuroinflammatory pathways

Microglial neuroinflammatory pathways represent the collective signaling networks and cellular responses of microglia, the primary innate immune cells of the central nervous system, to pathological stimuli (NIH, 2020; Frontiers, 2022). These pathways are triggered by the recognition of pathogen-associated or damage-associated molecular patterns (PAMPs/DAMPs) via receptors such as Toll-like receptors (TLRs) and the NLRP3 inflammasome (MDPI, 2020; NIH, 2020). Activation of these cascades typically leads to the nuclear translocation of transcription factors like NF-kappaB and the subsequent release of pro-inflammatory mediators, including cytokines (TNF-alpha, IL-1beta) and reactive oxygen species (NIH, 2020; ResearchGate, 2024). While initially a protective mechanism for tissue repair and debris clearance, chronic or excessive microglial activation drives neurotoxicity and contributes to the progression of neurodegenerative disorders like Alzheimer's and Parkinson's diseases (ScienceDaily, 2024; NIH, 2025). Therapeutic interventions aim to modulate these pathways to suppress neurotoxic phenotypes or promote a transition toward homeostatic and neuroprotective microglial states (BioWorld, 2022; Frontiers, 2024).

Other names

Microglial activation pathwaysNeuroimmune signaling pathwaysMicroglia-mediated neuroinflammationMicroglial inflammatory signaling

Modulation of microglial polarization from pro-inflammatory (M1-like) to anti-inflammatory (M2-like) states, inhibition of pro-inflammatory signaling cascades such as NF-kB, NLRP3, and JAK/STAT, and enhancement of phagocytic clearance of protein aggregates and cellular debris (NIH, 2020; MDPI, 2020; ResearchGate, 2024).